Effect of Lachnum YM156 Polyphenol on STAT3/COX-2 Signal Pathway and Gut Microbiota in Mice with N-Nitrosodiethylamine-Induced Hepatic Injury
Experimental approach. The hepatoprotective and microbiota-modulating efficacy of extracellular polyphenols from Lachnum YM156 (LSP156) was evaluated in an NDEA-induced mouse model. Sixty male Institute of Cancer Research (ICR) mice were randomised into six experimental groups receiving 28-day oral LSP156 treatment. Body mass measurements, hepatosomatic indices, systemic oxidative stress biomarkers (superoxide dismutase [SOD] and malondialdehyde) and proinflammatory cytokines (interleukin [IL]-6 and tumour necrosis factor [TNF]-α) were assessed. Hepatic histopathology was analysed by haemotoxylin and eosin staining, whereas immunoblotting with chemiluminescence detection assessed the STAT3/COX-2 pathway activation. Gut microbiota composition was profiled through 16S rRNA sequencing.
Results and conclusions. After 28-day oral administration (50–100 (mg/kg)/day), LSP156 significantly improved somatic growth parameters (body mass gain) and organ indices in NDEA-induced mice. LSP156 increased the activities of SOD and catalase, as well as glutathione levels, and greatly reduced the liver function markers alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and total bilirubin. It also improved liver cell damage in tissue samples compared to model controls. LSP156 halted the activation of STAT3 and reduced TLR4 levels, which lowered cyclooxygenase protein levels and protected the liver from damage. LSP156 enhanced the digestion and absorption of carbohydrates and proteins, as well as the biosynthesis of terpenoids such as ubiquinone in mice, by rectifying intestinal flora imbalances, modifying the flora structure and demonstrating a strong correlation between Bacteroidales and Lactobacillales with the reduction of TNF-α and IL-6. The LSP156 demonstrated dose-dependent therapeutic efficacy in attenuating oxidative stress, hepatocyte impairment and systemic inflammation.
Novelty and scientific contribution. Fungal polyphenol LSP156 maintains balanced gut bacteria by simultaneously managing inflammation and oxidation. These findings suggest a new approach to designing drugs that target multiple factors in complex metabolic disorders.
No keywords indexed for this article. Browse by subject →
Ian Rowland, Glenn Gibson, Almut Heinken et al.
Anupriya Tripathi, Justine Debelius, David A. Brenner et al.
Chathur Acharya, Jasmohan S. Bajaj
Caroline A Schneider, Wayne S Rasband, Kevin W Eliceiri
Anthony M. Bolger, Marc Lohse, Bjoern Usadel
J Gregory Caporaso, Justin Kuczynski, Jesse Stombaugh et al.
Torbjørn Rognes, Tomáš Flouri, Ben Nichols et al.
Marian Valko, Dieter Leibfritz, Jan Moncol et al.
C. A. Woodhouse, V. C. Patel, A. Singanayagam et al.
Liam Chung, Erik Thiele Orberg, Abby L. Geis et al.
João Sabino, Sara Vieira-Silva, Kathleen Machiels et al.
- Published
- Oct 01, 2025
- Vol/Issue
- 63(4)
- Pages
- 470
- License
- View
You May Also Like
Sindhu Raveendran, Binod Parameswaran · 2018
593 citations
Arijana Bušić, Nenad Marđetko · 2018
436 citations
Burcu Çabuk, Matthew G. Nosworthy · 2018
132 citations
Sabina Galus, Justyna Kadzińska · 2016
119 citations
Aleksandra S. Velićanski, Dragoljub D. Cvetković · 2014
98 citations